Company / Free Cash Flow per Share
AMICUS THERAPEUTICS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.10
FY2025
5-year range
-$0.79 / $0.10
FY2021-FY2025
Trend
+178.3%
vs FY2024
Sector context
#63 of 192
Health Care
What the data says
At $0.10, AMICUS THERAPEUTICS, INC.'s free cash flow per share ranks #63 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 7 consecutive years, from $-1.65 in FY2018 to $0.10 in FY2025.
Based on SEC 10-K filings.
0.10 in FY2025.
Improved from $-0.27 to $0.10 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#63 of 192 in Health CareTop 33% of 192This company $0.10 Sector average -$19.84
▼
+100.5% above sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s free cash flow per share has grown for 7 consecutive years.
- In FY2025, free cash flow per share increased 178.3% year-over-year.
- Ranks #63 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | +178.3% |
| FY2024 | -$0.13 | +53.2% |
| FY2023 | -$0.27 | +55.4% |
| FY2022 | -$0.61 | +22.4% |
| FY2021 | -$0.79 | +13.8% |
| FY2020 | -$0.91 | +18.8% |
| FY2019 | -$1.12 | +31.8% |
| FY2018 | -$1.65 | -7.8% |
| FY2017 | -$1.53 | -22.5% |
| FY2016 | -$1.25 | -13.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026